Myriad Genetics Inc

19. Aug. 2026, 20:02 UTC

Myriad Genetics shares are trading higher, rebounding from pre-market losses amid strong buying interest during the session. The stock remains near its one-month low.

18. Aug. 2026, 20:03 UTC

Myriad Genetics shares are trading lower amid an investigation and revised revenue guidance of $770-$790 million, down from $860-$880 million.

17. Aug. 2026, 19:26 UTC

Myriad Genetics Inc. shares are higher today, reaching a peak late in the session, though they remain below their 20-day moving average.

14. Aug. 2026, 19:46 UTC

Myriad Genetics Inc. shares are lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC, and disappointing Q2 results with revised revenue guidance.

13. Aug. 2026, 19:41 UTC

Myriad Genetics shares are lower as the company faces an investigation and lowers its full-year revenue guidance to $770-$790 million.

12. Aug. 2026, 19:31 UTC

Myriad Genetics Inc shares are lower as the company faces an investigation and reports declining Q2 revenue of $190.7 million, missing expectations.

11. Aug. 2026, 20:06 UTC

Myriad Genetics Inc shares are lower amid a securities investigation and disappointing Q2 results, which included a revenue decline and lowered full-year guidance.

7. Aug. 2026, 19:51 UTC

Myriad Genetics shares are higher today, driven by a broader advance in biotechnology stocks. The move breaks from a recent pattern of higher daily closes.

6. Aug. 2026, 20:03 UTC

Shares of Myriad Genetics are trading higher today, despite fluctuations during the session. The overall trend remains positive since Wednesday's close.

5. Aug. 2026, 21:21 UTC

Myriad Genetics Inc shares are higher in after-market hours, reflecting broader market gains amid positive technology stock performance and favorable economic data.

4. Aug. 2026, 20:04 UTC

Myriad Genetics shares are higher today, supported by overall market gains and positive sentiment amid declining crude oil prices and comments on potential peace talks with Iran.

3. Aug. 2026, 20:03 UTC

Myriad Genetics gains amid broader market strength, tightening revenue guidance to $770 million to $790 million while facing reimbursement challenges. Shares remain higher since Friday.

31. Juli 2026, 23:11 UTC

Myriad Genetics Inc shares are higher in after-market hours, recovering from earlier lows. The stock remains below its 20-day moving average.

30. Juli 2026, 22:51 UTC

Myriad Genetics shares fell in after-market trading following disappointing Q2 results, with revenue of $190.7 million missing expectations and a revised revenue outlook.

29. Juli 2026, 18:07 UTC

Myriad Genetics Inc. shares are lower today, continuing a four-session decline amid broader market concerns over rising crude oil prices and inflation worries.

28. Juli 2026, 18:06 UTC

Myriad Genetics faces negative sentiment after being labeled unprofitable. Shares are lower today, continuing a trend of declines over the past three sessions.

27. Juli 2026, 18:16 UTC

Myriad Genetics shares are lower amid a broader market trend and significant declines in crude oil prices, despite earlier session volatility.

24. Juli 2026, 19:36 UTC

Myriad Genetics shares are lower amid scrutiny over financial performance and stagnant revenue growth, reflecting ongoing challenges in the broader market.

22. Juli 2026, 20:06 UTC

Myriad Genetics Inc shares are lower today, continuing a decline from Tuesday's close amid mixed sentiment ahead of the Federal Reserve meeting.

20. Juli 2026, 18:22 UTC

Myriad Genetics Inc. shares are lower today, continuing a recent decline amid rising U.S. Treasury yields and inflation concerns tied to increasing oil prices.